Every injectable drug, vaccine and implanted device sold in the United States has to prove it is free of bacterial endotoxin. For half a century the test has depended on the milky-blue blood of an animal older than trees. In 2024, American labs bled more than a million of them.
American horseshoe crabs (Limulus polyphemus) collected and bled coastwide by biomedical facilities in 2024 — the first year past a million. An estimated 184,693 died as a result. — ASMFC, 2025
Horseshoe crab blood carries amebocytes that gel on contact with the outer membrane of gram-negative bacteria. Harvested as Limulus amebocyte lysate (LAL), that reflex became the world's endotoxin detector. Its floor is absurdly low — and it has to be, because the human limits it polices are lower still.
EU per kilogram of body weight per hour — the general ceiling for injectable drugs under USP <85>.
EU/kg/hour for drugs delivered into the spinal fluid. The central nervous system tolerates 25× less.
The year the FDA approved LAL for testing drugs, devices and anything that meets blood — retiring the rabbit pyrogen test.
Crabs are taken for two reasons. The biomedical industry bleeds them — up to about a third of their hemolymph — and returns most of them alive. The whelk and eel bait fishery kills every crab it lands. The ASMFC set a biomedical mortality threshold of 57,000 a year; it has been passed almost every year since 2007.
Of a crab's hemolymph volume is the industry cap. An adult holds roughly 200–400 mL in total.
Applied by ASMFC to every bled-and-released crab. Published estimates range from 8.3% to 29.8%.
Crabs collected for LAL that year, plus 570,988 landed as bait. The biomedical figure has risen since.
Rufa red knots fly from Tierra del Fuego to the Arctic and refuel almost entirely on horseshoe crab eggs in Delaware Bay. Their spring counts tracked the crab harvest down. The 2021 count was the lowest since surveys began in 1981; numbers have since climbed back, but to a fraction of the 1980s.
ASMFC assesses the American horseshoe crab as four separate populations from Maine to Florida. In the 2024 update, Delaware Bay and the Southeast came back good, the Northeast neutral, and New York poor — the only region that has trended downward across successive assessments.
Factor C is the single molecule that starts the clotting cascade. It was cloned in 1997 and can be brewed in cell culture with no crab involved. Europe's pharmacopoeia accepted recombinant Factor C in 2020; the U.S. Pharmacopeia's chapter <86> became official on 1 May 2025. Adoption, not approval, is now the bottleneck.
Horseshoe crabs a year in North America that could be spared if testing switched to recombinant reagents, per a 2018 PLOS Biology analysis. Modelled, not observed.
Horseshoe crab species are Asian, harvested with little regulation and near-total mortality. Conservation biologists warn that recombinant reagents do not touch the bigger threats: habitat loss and coastal development.
The lineage predates the dinosaurs, the Atlantic Ocean and the first forests. Its modern status is less impressive.
Years. Lunataspis aurora, the oldest known horseshoe crab, from Late Ordovician rock in Manitoba — 4 cm long, and already the right shape.
Limulus polyphemus, reclassified from near threatened in 2016.
Tachypleus tridentatus, Asia's bled species. Two further Asian species are data deficient.
This is not a story about a cruel industry and a doomed animal — the American stock is, coastwide, in decent shape, and the test itself has prevented an unknowable number of fatal fevers. It is a story about a dependency that no longer needs to exist. The detector molecule has been synthesisable for nearly thirty years; the regulatory door finally opened in 2025. What happens next is a procurement decision, taken one manufacturer at a time.
Like this? Get a new data story in your inbox every morning.